Functional Cell Line Development (MJ006889)
2-2.4万
 上海
 无需经验
 博士
 传播学、英语
 全职
 更新于03-10
方案
收藏
先聊聊
职位信息

Biologics and bioconjugate therapeutics (such as monoclonal antibody, bispecifics, antibody-drug conjugate) rapidly emerge as the most effective way in the treatment of autoimmune disease, cancer, diabetes and various rare diseases. 9 out of top 10 best-selling drugs by revenue in 2024 are biologics, compared to 0 out of 10 in 2003 and 3 out of 10 in 2012.
WuXi XDC is a leading Contract Research, Development and Manufacturing Organization (CRDMO) focused on the global ADC and broader bioconjugate market, is a pioneering CRDMO offering integrated, end-to-end services. Services are provided from proximately located, state-of-the-art laboratories and manufacturing facilities, allowing for a significant reduction in development timelines and costs.
Responsibilities:
Engineer in-vitro functional stable cell lines to support therapeutic antibody and bioconjugate product development using viral (e.g., lentivirus, AAV) and non-viral methods (e.g., CRISPR-Cas9).
Develop and optimize cell lines through high-throughput screening, isolation, and validation of target-expressing cell populations.
Lead and mentor junior scientists to advance cross-functional project goals and foster team collaboration.
Design and implement cell-based functional assays to assess therapeutic mechanism of action (MOA), potency, and critical quality attributes (CQAs) for in-process and final product release testing.
Ensure regulatory compliance by following instrument calibration, personnel training, and end-to-end documentation (drafting, review, archival).
Support biologics regulatory submissions (e.g., INDs, BLAs) at WuXi XDC, including direct engagement with global agencies (US FDA, China NMPA) as required.
Basic Qualifications:
PhD or MS in Biochemistry/Biotechnology, Cell Biology, Immunology, or related field.
0-5 years for PhD or 5-10 years for MS of industrial experience in cell line development
Strong technical innovation and trouble-shooting skills in cell biology, molecular biology and biochemical research.
In-depth knowledge of molecular biological techniques, cell signaling transduction, and / or immune regulation knowledge.
Excellent spoken and written communication skills in English is a must.
Experience with use of electronic lab notebook and regulatory filings is preferred.
工作地址
 上海药明合联生物技术有限公司
应届生安全提醒
求职过程中如果遇到违规收费、信息不实、以招聘名义的培训收费或者微信营销等虚假招聘行为,请保留证据,维护自己的合法权益。谨防上当受骗!
公司信息
药明生物(股票代码:2269.HK)是一家全球领先的合同研究、开发和生产(CRDMO)服务公司。公司通过开放式、一体化生物制药能力和技术赋能平台,提供全方位的端到端服务,帮助合作伙伴发现、开发及生产生物药,实现从概念到商业化生产的全过程,加速全球生物药研发进程,降低研发成本,造福病患。
药明生物在中国、美国、爱尔兰、德国和新加坡拥有超过12000名员工。通过药明生物人的专业服务团队,以及先进技术和精深洞见,公司为客户提供高效经济的生物药解决方案。截至2023年6月底,药明生物帮助客户研发和生产的综合项目高达621个,其中包括22个商业化生产项目。
药明生物拥有遍布全球的CRDMO基地,包括3个药物发现中心、8个药物开发中心以及9个生产基地,其中
? 3个药物发现中心位于中国上海外高桥、上海奉贤、美国波士顿;
? 8个药物开发中心位于中国上海外高桥、无锡、上海奉贤、成都、杭州、苏州;美国新泽西州克兰伯里;新加坡;
? 9个生产基地位于中国无锡、石家庄、成都、杭州;德国伍珀塔尔、勒沃库森;爱尔兰敦多克;美国马萨诸塞州伍斯特;新加坡。
下载App 查看公司其他职位
公司信息更多职位
img上海药明生物技术有限公司
民营
10000人以上
制药/生物工程
有大佬到终面了吗?
我的都还没有评估呢,你的第一轮评估结束了吗
身份验证怎么过呀 你们谁能试过了
大学生身份认证嘛?我是根据上面的提示步骤操作的
请问大家进度到哪了?
蹲蹲,有消息了吗?
下载App 参与互动